A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy

BACKGROUND: Multiple system atrophy (MSA) is a progressive, neurodegenerative disease characterized by parkinsonism, resistance to dopamine therapy, ataxia, autonomic dysfunction, and pathological accumulation of α-synuclein (α-syn) in oligodendrocytes. Neurosin (kallikrein-6) is a serine protease c...

Descripción completa

Detalles Bibliográficos
Autores principales: Spencer, Brian, Valera, Elvira, Rockenstein, Edward, Trejo-Morales, Margarita, Adame, Anthony, Masliah, Eliezer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580347/
https://www.ncbi.nlm.nih.gov/pubmed/26394760
http://dx.doi.org/10.1186/s13024-015-0043-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580347/
https://www.ncbi.nlm.nih.gov/pubmed/26394760
http://dx.doi.org/10.1186/s13024-015-0043-6

Ejemplares similares